IL12 Integrated into the CAR Exodomain Converts CD8⁺ T Cells to Poly-Functional NK-Like Cells with Superior Killing of Antigen-Loss Tumors

To reprogram the functional capacities specifically of engineered CAR T cells, the authors inserted IL12 into the extracellular moiety of a CD28-ζ CAR.